Intravenous Solution Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition); Nutritional Content ( Amino Acid Solution, Parenteral lipid Emulsion, Carbohydrates, Vitamins and Minerals, Other)

Report Code: TIPRE00019751 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Intravenous solutions are fluids that are directed through a patient's bloodstream. Sterile fluids are used to support patients with extreme dehydration. There are different types of IV consumer strategies available. In order to obtain an intravenous solution, many companies produce intravenous fluids or compounds that can be combined with clean water.

MARKET DYNAMICS

In the coming years, malnutrition, especially for the elderly, is expected to increase the demand for IV solutions due to chronic diseases such as cancer. Dehydration is one of the frequent adverse effects of cancer. Chemotherapy induces dehydration due to adverse reactions such as vomiting, diarrhoea and frequent urination.

MARKET SCOPE

The "Intravenous Solution Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Intravenous Solution Market with detailed market segmentation by type, and nutritional content. The Intravenous Solution Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Intravenous Solution Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Intravenous Solution Market is segmented on the basis of type, nutritional content. Based on type, the market is segmented as Peripheral Parenteral Nutrition and Total Parenteral Nutrition. Based on nutritional content, the market is segmented as Amino Acid Solution, Parenteral lipid Emulsion, Carbohydrates, Vitamins and Minerals, Other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Intravenous Solution Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Intravenous Solution Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Intravenous Solution Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Intravenous Solution Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Intravenous Solution Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Intravenous Solution Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Intravenous Solution Market in the global market. Below mentioned is the list of few companies engaged in the Intravenous Solution Market.

The report also includes the profiles of key players in Intravenous Solution Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Ajinomoto
  •   B. Braun Melsungen AG
  •   Grifols
  •   ICU Medical, Inc.
  •   Baxter International
  •   Hospira
  •   Terumo Corporation
  •   JW Life Science
  •   Terumo Corporation
  •   Amanta Healthcare

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intravenous Solution Market - By Type
1.3.2 Intravenous Solution Market - By Nutrition Content
1.3.3 Intravenous Solution Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTRAVENOUS SOLUTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRAVENOUS SOLUTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRAVENOUS SOLUTION MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRAVENOUS SOLUTION - GLOBAL MARKET OVERVIEW
6.2. INTRAVENOUS SOLUTION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INTRAVENOUS SOLUTION MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PERIPHERAL PARENTERAL NUTRITION AND TOTAL PARENTERAL NUTRITION
7.3.1. Overview
7.3.2. Peripheral Parenteral Nutrition and Total Parenteral Nutrition Market Forecast and Analysis
8. INTRAVENOUS SOLUTION MARKET - REVENUE AND FORECASTS TO 2027 - NUTRITION CONTENT
8.1. OVERVIEW
8.2. NUTRITION CONTENT MARKET FORECASTS AND ANALYSIS
8.3. AMINO ACID SOLUTION
8.3.1. Overview
8.3.2. Amino Acid Solution Market Forecast and Analysis
8.4. PARENTERAL LIPID EMULSION
8.4.1. Overview
8.4.2. Parenteral lipid Emulsion Market Forecast and Analysis
8.5. CARBOHYDRATES
8.5.1. Overview
8.5.2. Carbohydrates Market Forecast and Analysis
8.6. VITAMINS AND MINERALS
8.6.1. Overview
8.6.2. Vitamins and Minerals Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. INTRAVENOUS SOLUTION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Intravenous Solution Market Overview
9.1.2 North America Intravenous Solution Market Forecasts and Analysis
9.1.3 North America Intravenous Solution Market Forecasts and Analysis - By Type
9.1.4 North America Intravenous Solution Market Forecasts and Analysis - By Nutrition Content
9.1.5 North America Intravenous Solution Market Forecasts and Analysis - By Countries
9.1.5.1 United States Intravenous Solution Market
9.1.5.1.1 United States Intravenous Solution Market by Type
9.1.5.1.2 United States Intravenous Solution Market by Nutrition Content
9.1.5.2 Canada Intravenous Solution Market
9.1.5.2.1 Canada Intravenous Solution Market by Type
9.1.5.2.2 Canada Intravenous Solution Market by Nutrition Content
9.1.5.3 Mexico Intravenous Solution Market
9.1.5.3.1 Mexico Intravenous Solution Market by Type
9.1.5.3.2 Mexico Intravenous Solution Market by Nutrition Content
9.2. EUROPE
9.2.1 Europe Intravenous Solution Market Overview
9.2.2 Europe Intravenous Solution Market Forecasts and Analysis
9.2.3 Europe Intravenous Solution Market Forecasts and Analysis - By Type
9.2.4 Europe Intravenous Solution Market Forecasts and Analysis - By Nutrition Content
9.2.5 Europe Intravenous Solution Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Intravenous Solution Market
9.2.5.1.1 Germany Intravenous Solution Market by Type
9.2.5.1.2 Germany Intravenous Solution Market by Nutrition Content
9.2.5.2 France Intravenous Solution Market
9.2.5.2.1 France Intravenous Solution Market by Type
9.2.5.2.2 France Intravenous Solution Market by Nutrition Content
9.2.5.3 Italy Intravenous Solution Market
9.2.5.3.1 Italy Intravenous Solution Market by Type
9.2.5.3.2 Italy Intravenous Solution Market by Nutrition Content
9.2.5.4 Spain Intravenous Solution Market
9.2.5.4.1 Spain Intravenous Solution Market by Type
9.2.5.4.2 Spain Intravenous Solution Market by Nutrition Content
9.2.5.5 United Kingdom Intravenous Solution Market
9.2.5.5.1 United Kingdom Intravenous Solution Market by Type
9.2.5.5.2 United Kingdom Intravenous Solution Market by Nutrition Content
9.2.5.6 Rest of Europe Intravenous Solution Market
9.2.5.6.1 Rest of Europe Intravenous Solution Market by Type
9.2.5.6.2 Rest of Europe Intravenous Solution Market by Nutrition Content
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Intravenous Solution Market Overview
9.3.2 Asia-Pacific Intravenous Solution Market Forecasts and Analysis
9.3.3 Asia-Pacific Intravenous Solution Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Intravenous Solution Market Forecasts and Analysis - By Nutrition Content
9.3.5 Asia-Pacific Intravenous Solution Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Intravenous Solution Market
9.3.5.1.1 Australia Intravenous Solution Market by Type
9.3.5.1.2 Australia Intravenous Solution Market by Nutrition Content
9.3.5.2 China Intravenous Solution Market
9.3.5.2.1 China Intravenous Solution Market by Type
9.3.5.2.2 China Intravenous Solution Market by Nutrition Content
9.3.5.3 India Intravenous Solution Market
9.3.5.3.1 India Intravenous Solution Market by Type
9.3.5.3.2 India Intravenous Solution Market by Nutrition Content
9.3.5.4 Japan Intravenous Solution Market
9.3.5.4.1 Japan Intravenous Solution Market by Type
9.3.5.4.2 Japan Intravenous Solution Market by Nutrition Content
9.3.5.5 South Korea Intravenous Solution Market
9.3.5.5.1 South Korea Intravenous Solution Market by Type
9.3.5.5.2 South Korea Intravenous Solution Market by Nutrition Content
9.3.5.6 Rest of Asia-Pacific Intravenous Solution Market
9.3.5.6.1 Rest of Asia-Pacific Intravenous Solution Market by Type
9.3.5.6.2 Rest of Asia-Pacific Intravenous Solution Market by Nutrition Content
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Intravenous Solution Market Overview
9.4.2 Middle East and Africa Intravenous Solution Market Forecasts and Analysis
9.4.3 Middle East and Africa Intravenous Solution Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Intravenous Solution Market Forecasts and Analysis - By Nutrition Content
9.4.5 Middle East and Africa Intravenous Solution Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Intravenous Solution Market
9.4.5.1.1 South Africa Intravenous Solution Market by Type
9.4.5.1.2 South Africa Intravenous Solution Market by Nutrition Content
9.4.5.2 Saudi Arabia Intravenous Solution Market
9.4.5.2.1 Saudi Arabia Intravenous Solution Market by Type
9.4.5.2.2 Saudi Arabia Intravenous Solution Market by Nutrition Content
9.4.5.3 U.A.E Intravenous Solution Market
9.4.5.3.1 U.A.E Intravenous Solution Market by Type
9.4.5.3.2 U.A.E Intravenous Solution Market by Nutrition Content
9.4.5.4 Rest of Middle East and Africa Intravenous Solution Market
9.4.5.4.1 Rest of Middle East and Africa Intravenous Solution Market by Type
9.4.5.4.2 Rest of Middle East and Africa Intravenous Solution Market by Nutrition Content
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Intravenous Solution Market Overview
9.5.2 South and Central America Intravenous Solution Market Forecasts and Analysis
9.5.3 South and Central America Intravenous Solution Market Forecasts and Analysis - By Type
9.5.4 South and Central America Intravenous Solution Market Forecasts and Analysis - By Nutrition Content
9.5.5 South and Central America Intravenous Solution Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Intravenous Solution Market
9.5.5.1.1 Brazil Intravenous Solution Market by Type
9.5.5.1.2 Brazil Intravenous Solution Market by Nutrition Content
9.5.5.2 Argentina Intravenous Solution Market
9.5.5.2.1 Argentina Intravenous Solution Market by Type
9.5.5.2.2 Argentina Intravenous Solution Market by Nutrition Content
9.5.5.3 Rest of South and Central America Intravenous Solution Market
9.5.5.3.1 Rest of South and Central America Intravenous Solution Market by Type
9.5.5.3.2 Rest of South and Central America Intravenous Solution Market by Nutrition Content
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTRAVENOUS SOLUTION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOINT VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INTRAVENOUS SOLUTION MARKET, KEY COMPANY PROFILES
12.1. AJINOMOTO
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. B. BRAUN MELSUNGEN AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GRIFOLS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ICU MEDICAL, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAXTER INTERNATIONAL
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HOSPIRA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TERUMO CORPORATION
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JW LIFE SCIENCE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TERUMO CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. AMANTA HEALTHCARE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Ajinomoto
2. B. Braun Melsungen AG
3. Grifols
4. ICU Medical, Inc.
5. Baxter International
6. Hospira
7. Terumo Corporation
8. JW Life Science
9. Terumo Corporation
10. Amanta Healthcare
TIPRE00019751
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking